Mode
Text Size
Log in / Sign up

Dermatitis Herpetiformis prevalence in Celiac Disease patients is 6.8% with high heterogeneityCeliac disease patients have higher risk of itchy skin condition

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that DH prevalence is 6.8% in CD patients, with higher rates observed in adults (8.6%) than children (2.6%).

This meta-analysis investigated the prevalence of Dermatitis Herpetiformis (DH) among patients diagnosed with Celiac Disease (CD). The analysis included a large sample size of 73,905 patients with celiac disease, which included 2,203 identified cases of DH. The study aimed to quantify how frequently this specific skin manifestation occurs within the broader population of individuals with gluten-sensitive enteropathy.

The primary outcome was the pooled prevalence of Dermatitis Herpetiformis in Celiac Disease patients. The analysis reported an overall pooled DH prevalence of 6.8% (95% CI: 5.0-9.3). In a specific subset of nonselected populations, the pooled prevalence was recorded at 6.7% (95% CI: 4.7-9.6). These figures provide a quantitative baseline for clinicians to understand the frequency of DH in patients with confirmed CD.

Secondary outcomes focused on demographic variations in prevalence. The data revealed significant differences between age groups; the prevalence of DH in pediatric CD was 2.6% (95% CI: 1.4-4.5), which was notably lower than the prevalence found in adult CD, which was reported at 8.6% (95% CI: 5.8-12.6). Furthermore, gender-specific data showed a prevalence of 12.9% (95% CI: 7.0-22.7) in males and 9.6% (95% CI: 3.7-22.9) in females.

Regarding safety and tolerability, no specific data on adverse events, serious adverse events, or treatment discontinuations were reported. The study focuses on prevalence rather than intervention outcomes, thus clinical tolerance of management protocols was not assessed within this specific analysis.

Methodologically, the study noted high heterogeneity (I = 98.9%). This indicates that the included studies varied significantly in their settings and populations, meaning the pooled estimate should be viewed as an average across diverse contexts rather than a single uniform figure applicable to every clinical setting. Additionally, it is important to note that gender-specific prevalence was based on only 5 of 24 studies; therefore, these specific figures are not directly comparable with the overall pooled estimate.

Clinically, these findings emphasize the need for standardized diagnostic approaches and more consistent reporting in clinical settings. The association between Celiac Disease and Dermatitis Herpetiformis is noted as sharing a pathophysiological basis. While the data provide clear evidence of the prevalence of DH in CD patients, the high heterogeneity suggests that local clinical practices may vary based on regional demographics. Questions remain regarding the specific factors driving the higher prevalence in adult populations compared to pediatric ones and how these figures translate into specific screening protocols for early detection of skin manifestations. The high variance underscores the importance of recognizing DH as a common, though variable, manifestation of Celiac Disease.

How this fits prior evidence

How this fits prior evidence This meta-analysis provides quantitative data on the prevalence of Dermatitis Herpetiformis in patients with celiac disease. While it does not directly overlap with previous reports on neuropsychiatric manifestations, Hashimoto's thyroiditis, NF-kB inhibition, genetic risk haplotypes, or hereditary alpha-tryptasemia, it addresses a gap in quantifying the frequency of cutaneous manifestations associated with the shared pathophysiological basis of celiac disease.

Living with celiac disease can be challenging. It is an autoimmune condition where the body reacts poorly to gluten, often causing internal issues like digestive problems. However, some people with this condition also deal with a specific skin problem called dermatitis herpetiformis. This skin condition causes intense itching and small, blister-like bumps. Because both conditions involve the immune system attacking the body in similar ways, they often go hand in hand. Understanding how common this skin issue is can help patients and doctors better manage symptoms.

To get a clearer picture of how these two conditions overlap, researchers looked at data from over 73,000 people with celiac disease. They specifically wanted to find out how many of those people also had the itchy skin condition. By looking across many different studies, they were able to calculate an average rate for the population.

The findings showed that about 6.8 percent of people with celiac disease also have dermatitis herpetiformis. While that might sound like a small number, it is important for those who are currently suffering from both conditions. The study also looked at how this affects different groups. They found that the skin condition is more common in adults than in children. Specifically, about 8.6 percent of adults with celiac disease had the skin issue, while only about 2.6 percent of children did. The data also showed that men and women both experience the skin condition at significant rates.

It is important to keep these findings in perspective. One reason for caution is that the data came from many different studies that were not all similar. This means the numbers are an average across many different settings, rather than a single rule that applies perfectly to every person. Also, because the study looked at such a wide variety of situations, some specific details about gender might be harder to compare directly. For patients right now, this research does not change immediate treatment plans or medications. However, it highlights why doctors should look for skin symptoms when treating celiac disease. It reminds medical teams that because these two conditions share a similar biological root, they need consistent ways to identify and treat both. If you have celiac disease and notice persistent itchy skin, this data confirms that such symptoms are a known part of the condition's landscape.

What this means for you:
About 7% of people with celiac disease also have dermatitis herpetiformis, which is more common in adults.

Study Details

Study typeMeta analysis
Sample sizen = 73,905
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Dermatitis herpetiformis (DH) shares a pathophysiological basis with celiac disease (CD), but its epidemiology remains poorly defined. This systematic review and meta-analysis estimated the prevalence of DH among CD patients. Following the PRISMA 2020 guidelines, PubMed, Embase, Web of Science, and Scopus were searched. Observational studies with extractable DH data in CD patients were pooled using a random-effects model, with subgroup and meta-regression analyses. The risk of bias was assessed using the JBI Checklist. Of 7271 records, 24 studies published between 1996 and 2023, comprising 73,905 patients with celiac disease and 2203 DH cases (crude prevalence: 3.0%), met the inclusion criteria. Pooled DH prevalence in CD was 6.8% (95% CI: 5.0-9.3). When restricting the analysis to nonselected populations, the pooled prevalence was 6.7% (95% CI: 4.7-9.6). Prevalence was lower in pediatric CD (2.6%, 1.4-4.5) than in adults (8.6%, 5.8-12.6). Gender-specific prevalence, based on 5 of the 24 studies and not directly comparable with the overall estimate, was 12.9% (7.0-22.7) in males and 9.6% (3.7-22.9) in females. Sensitivity analyses yielded comparable estimates across all models (range: 6%-9%), indicating that the results were consistent across different methodological assumptions and not driven by specific study characteristics. Given the very high heterogeneity (I = 98.9%), the pooled estimate should be interpreted as an average across diverse settings rather than a single generalizable figure. These findings emphasize the need for standardized diagnostic approaches and more consistent reporting in clinical settings. TRIAL REGISTRATION: PROSPERO (CRD42023444060).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.